WE LOVE YOUR FAT
Live / Registered — Registered (as of 02 Jan 2024)
What this means for you
Registered since 02 Jan 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97458501
- Registration number
- 7257671
- Mark type
- Stylized text
- Filed
- 14 Jun 2022
- Published for opposition
- 17 Oct 2023
- Registered
- 02 Jan 2024
- Attorney of record
- Steven Ivy
Goods and services
- Class 035 — Advertising and business services: Business consulting services in the field of stem cells.; Business consulting services in the field of specialized medical services and products, namely, microfat processing system used for extracting cells from patient's own blood and converting it into medication for treatment of musculoskeletal disorders, degenerative and inflammatory conditions, dermatological conditions, reduction of pain, rejuvenation of skin, treatment of sexual dysfunctions, restoration of hair, and accelerating healing of wounds.; International business consulting services relating to specialized medical services and products, namely, microfat processing system used for extracting cells from patient's own blood and converting it into medication for treatment of musculoskeletal disorders, degenerative and inflammatory conditions, dermatological conditions, reduction of pain, rejuvenation of skin, treatment of sexual dysfunctions, restoration of hair, and accelerating healing of wounds.; International business consulting services relating to stem cells.; Operating on-line marketplaces featuring medical products used for the extraction from blood and processing of regenerative stem cells.; Promoting public awareness of specialized medical services and products, used for extraction and processing of regenerative human cells.; Promoting public awareness of medical services relating to the removal, processing of human blood.; Promoting public awareness of specialized medical services and products, namely, microfat processing system used for extracting cells from patient's own blood and converting it into medication for treatment of musculoskeletal disorders, degenerative and inflammatory conditions, dermatological conditions, reduction of pain, rejuvenation of skin, treatment of sexual dysfunctions, restoration of hair, and accelerating healing of wounds.; Promoting public awareness of medical services relating to the removal, processing of stem cells and treatment of medical conditions with the processed stem cells.; Providing purchase advisory and consulting services to consumers for the purchase of medical devices used for removal, treatment and processing of stem cells.; Providing purchase advisory and consulting services to consumers for the purchase of medical products, namely, microfat processing system used for extracting cells from patient's own blood and converting it into medication for treatment of musculoskeletal disorders, degenerative and inflammatory conditions, dermatological conditions, reduction of pain, rejuvenation of skin, treatment of sexual dysfunctions, restoration of hair, and accelerating healing of wounds.; Wholesale distributorships featuring medical products, namely, microfat processing system used for extracting cells from patient's own blood and converting it into medication for treatment of musculoskeletal disorders, degenerative and inflammatory conditions, dermatological conditions, reduction of pain, rejuvenation of skin, treatment of sexual dysfunctions, restoration of hair, and accelerating healing of wounds
Owner
- Jointechlabs Inc., Saint Charles, IL, US
- Jointechlabs Inc., Saint Charles, IL, US
- Jointechlabs Inc., Saint Charles, IL, US
Prosecution history
- 02 Jan 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 02 Jan 2024 — REGISTERED-PRINCIPAL REGISTER
- 17 Oct 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 17 Oct 2023 — PUBLISHED FOR OPPOSITION
- 27 Sept 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 14 Sept 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 13 Sept 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 12 Sept 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 12 Sept 2023 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 21 Jun 2023 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 21 Jun 2023 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 27 Mar 2023 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 27 Mar 2023 — NON-FINAL ACTION E-MAILED
- 27 Mar 2023 — NON-FINAL ACTION WRITTEN
- 27 Mar 2023 — ASSIGNED TO EXAMINER